Javitt Daniel C. 4
4 · NRX Pharmaceuticals, Inc. · Filed Dec 1, 2022
Insider Transaction Report
Form 4
Javitt Daniel C.
10% Owner
Transactions
- Sale
common stock
2022-11-30$1.50/sh−8,441$12,700→ 9,634,793 total(indirect: By LLC) - Sale
common stock
2022-11-29$1.50/sh−13,730$20,651→ 9,643,234 total(indirect: By LLC)
Footnotes (2)
- [F1]Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
- [F2]Held by Glytech LLC of which the Reporting Person is the sole owner.